Tirzepatide noninferior to dulaglutide with respect to composite of death from cardiovascular causes, myocardial infarction, ...

- Reduced inflammation at the site of myocardial infarction and improved heart function demonstrated. Novel therapy to modulate immune response with apoptotic cell-derived nanovesicles. Myocardial ...

Global and genetic analyses link low physical activity to rising heart disease mortality, while higher activity levels appear ...

Myocardial infarction with nonobstructive coronary arteries (MINOCA) is a heterogeneous condition with diverse underlying causes, including atherosclerotic and nonatherosclerotic mechanisms. A ...

For women with severe CAD, percutaneous coronary intervention is associated with increased risk for MACCE and all-cause mortality compared with CABG.

Every minute counts after the onset of myocardial infarction (MI). Modern treatment with thrombolytic agents can lyse the clot in the coronary artery in patients with infarction and, by doing so, ...

Patients with HIV face a significantly higher 30-day readmission risk following hospitalization for HF or AMI compared with those without HIV.